Frank Reed

Honda scraps key EV models and forecasts its first annual loss since 1977, signaling a massive industry pivot from electric dreams to hybrid reality.

The specialty infusion provider is the first to earn a rigorous new distinction, signaling a major leap forward in patient safety and quality of care.

With new clinical data and a clear path to Phase 2 trials, Gain Therapeutics' GT-02287 offers hope for a disease-modifying therapy for Parkinson's.

Hyperproof's new FedRAMP Moderate status promises to modernize government compliance, bridging the gap between agile software and high-security GRC solutions.

Alectra Utilities is investing $46 million to upgrade Mississauga's aging power grid, aiming to support massive urban growth and prevent outages.

With three veteran bankers joining its ranks, Camden National Bank is making an aggressive play for New Hampshire's competitive commercial market.

At Japan IT Week, ARBOR Technology unveils hardware with NVIDIA Blackwell and AMD EPYC, bringing data center power to the world's harshest environments.

With a nursing shortage looming, the AACN's new board, led by simulation pioneer Valerie Howard, is poised to transform education and the workforce.

A new pilot in South Africa will test foldable shipping containers that could slash costs, cut emissions, and revolutionize the global freight industry.

GIX hires Prudential veteran Kevin C. Buckley as CFO, signaling a major push to launch its sustainability-focused stock exchange by late 2026.

The world's largest prediction market is partnering with a controversial data giant to ensure integrity. But what is the price of a clean market?

PowerBank Corp. secures millions in state funding to build a community solar farm on a former industrial site, promising lower energy bills for 875 homes.

A White House-backed program is fast-tracking electric air taxis, with Joby Aviation set to begin early operations across the U.S. in 2026.

Strong Q4 results and a leaner focus signal a potential turnaround for the powersports giant, but questions about cash flow remain for the road ahead.

With a new chairman at the helm, NATSO's 2026 board is set to navigate the complex challenges of EV charging, new regulations, and evolving customer demands.

Medicus Pharma's microneedle patch for basal cell carcinoma clears nearly three-quarters of lesions, offering a potential non-surgical alternative to the scalpel.

After years of rapid growth to a $400M run rate, telecom firm IQSTEL is shifting its focus to profits. Can it turn its massive scale into shareholder value?

Honored as a top SaaS leader, April Stiles is pioneering responsible AI in healthcare. See how her vision is driving growth and innovation at Perspecta.

With its runway extended by insiders, the biotech firm bets on its promising glioblastoma drug and an unconventional strategy of crypto and acquisitions.

Vaalco Energy's Gabon exploration well came up dry, but a pre-planned pivot to a development well highlights strategic resilience and wins market confidence.